Indoco has tripled its operating profit in its financial first quarter ended 30 June 2020. The company has also received FDA approval for its generic version of Eli Lilly’s Zyprexa.

Urology device developer NeoTract, which Teleflex purchased in 2017, is now under scrutiny for potential FCA violations. 

New York biotech is partnering with researchers at Columbia, Kansas State and Southern Research to address the pandemic.

Phase II/III studies are underway for Mesoblast’s remestemcel-L and Athersys’ Multistem, followed by a pack of earlier-stage stem cell candidates from Pluristem, Hope Bioscience and Celltex – with an interactive chart of the COVID-19 cell therapy pipeline.